Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Minority Interest (2016)

United Therapeutics (UTHR) has disclosed Minority Interest for 8 consecutive years, with $10.9 million as the latest value for Q4 2016.

  • Quarterly Minority Interest changed 0.0% to $10.9 million in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $10.9 million through Dec 2016, changed 0.0% year-over-year, with the annual reading at $10.9 million for FY2016, 0.0% changed from the prior year.
  • Minority Interest hit $10.9 million in Q4 2016 for United Therapeutics, roughly flat from $10.9 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $10.9 million in Q4 2015 to a low of $10.9 million in Q1 2012.
  • Historically, Minority Interest has averaged $10.9 million across 5 years, with a median of $10.9 million in 2012.
  • Biggest five-year swings in Minority Interest: changed 0.0% in 2012 and later grew 0.17% in 2015.
  • Year by year, Minority Interest stood at $10.9 million in 2012, then changed by 0.0% to $10.9 million in 2013, then changed by 0.0% to $10.9 million in 2014, then grew by 0.17% to $10.9 million in 2015, then changed by 0.0% to $10.9 million in 2016.
  • Business Quant data shows Minority Interest for UTHR at $10.9 million in Q4 2016, $10.9 million in Q4 2015, and $10.9 million in Q3 2015.